ctrl K

AI Score

Unlock

Lexeo Therapeutics Inc. C... (LXEO)

AI Score

Unlock

4.09

-0.02 (-0.49%)

At close: Mar 28, 2025, 3:59 PM

3.93

-3.91%

After-hours: Mar 28, 2025, 04:49 PM EDT

Lexeo Therapeutics Common Stock Income Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20
Revenue	n/a	n/a	654K	1.66M	518.48K
Cost of Revenue	n/a	1.84M	1.15M	13.4K	n/a
Gross Profit	n/a	-1.84M	-491K	1.64M	518.48K
Operating Income	n/a	-68.51M	-60.51M	-50.64M	-4.59M
Interest Income	7.56M	2.87M	1.32M	15K	n/a
Pretax Income	-98.33M	-66.39M	-59.28M	-50.62M	-5.15M
Net Income	-98.33M	-66.39M	-59.28M	-50.62M	-5.15M
Selling & General & Admin	31.68M	13.54M	12M	7.17M	787.5K
Research & Development	74.09M	53.13M	49.16M	45.12M	4.32M
Other Expenses	n/a	n/a	-2K	-155	4.24K
Operating Expenses	105.77M	66.67M	61.16M	52.29M	5.11M
Interest Expense	-137K	205K	91K	n/a	147.15K
Selling & Marketing Expenses	n/a	-1.84M	n/a	n/a	n/a
Cost & Expenses	n/a	68.51M	61.16M	52.29M	5.11M
Income Tax	n/a	n/a	89K	-155	147.15K
Shares Outstanding (Basic)	31.79M	26.65M	24.67M	24.67M	24.67M
Shares Outstanding (Diluted)	31.79M	26.65M	24.67M	24.67M	24.67M
EPS (Basic)	-3.09	-2.49	-2.4	-2.05	-0.21
EPS (Diluted)	-3.09	-2.49	-2.4	-2.05	-0.21
EBITDA	n/a	-66.67M	-58.04M	-50.62M	-4.58M
Depreciation & Amortization	n/a	1.84M	1.15M	13.4K	4.24K